Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Buy Now

Data Insights

JTE-162 is under clinical development by Japan Tobacco and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...

Data Insights

JTE-162 is under clinical development by Japan Tobacco and currently in Phase I for Inflammation. According to GlobalData, Phase I...

Data Insights

JTE-162 is under clinical development by Japan Tobacco and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...

Data Insights

JTE-162 is under clinical development by Japan Tobacco and currently in Phase I for Inflammation. According to GlobalData, Phase I...